SCHEMBL1404485

SCHEMBL1404485

CC(C)(C)OC(=O)CCN(CCN)CC(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.39
BLM P54132 2/20 0.39
PMP22 Q01453 2/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
CHRM2 P08172 1/20 0.39
ADRA2A P08913 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
DRD1 P21728 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
CYP2C19 P33261 1/20 0.39
ADRA1A P35348 1/20 0.39
DRD3 P35462 1/20 0.39
SLC6A3 Q01959 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
EYA2 O00167 1/20 0.36
APP P05067 1/20 0.36
ACE P12821 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3661157 0.90 STING1 (0.31) STING1
SCHEMBL6534869 0.88 STING1 (0.33) CA1STING1
SCHEMBL17177620 0.87 TSHR (0.32) TDP1BLMPMP22KDM4ELMNA
SCHEMBL6859731 0.87 TDP1 (0.47) TDP1BLMPMP22KDM4ELMNA
SCHEMBL2185399 0.87 TDP1 (0.43) TDP1BLMPMP22KDM4ELMNA
Hydrochloric Acid SCHEMBL6840669 0.86 MEN1 (0.34) CA1STING1
SCHEMBL18362362 0.83 NR1D1 (0.33) CA1
SCHEMBL7203322 0.80 TDP1 (0.38) TDP1BLMPMP22KDM4ELMNA
SCHEMBL18752977 0.79 CA14 (0.38) TDP1BLMPMP22KDM4ELMNA
SCHEMBL2185396 0.79 NR1D1 (0.35) TDP1EYA2APPACECA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10036066-B2 In situ hybridization detection method DAKO DENMARK A/S (DK) 2018-07-31 US disclosed
US-9598720-B2 Monomeric and polymeric linkers useful for conjugating biological molecules and other substances DAKO DENMARK A/S (DK) 2017-03-21 US disclosed
US-20160273035-A1 IN SITU HYBRIDIZATION DETECTION METHOD DAKO DENMARK A/S (DK) 2016-09-22 US disclosed
EP-1919930-B1 NEW NUCLEIC ACID BASE PAIRS DAKO DENMARK AS (DK) 2016-09-14 EP disclosed
US-9017992-B2 In situ hybridization detection method DAKO DENMARK A/S (DK) 2015-04-28 US disclosed
EP-1910575-B1 IMMUNOHISTOCHEMISTRY DETECTION METHOD DAKO DENMARK AS (DK) 2014-12-10 EP disclosed
US-8741566-B2 Immunohistochemistry and in situ hybridization detection method DAKO DENMARK A/S (DK) 2014-06-03 US disclosed
US-20140080145-A1 Monomeric and Polymeric Linkers Useful For Conjugating Biological Molecules and Other Substances DAKO DENMARK A/S (DK) 2014-03-20 US disclosed
US-8546309-B2 Monomeric and polymeric linkers useful for conjugating biological molecules and other substances DAKO DENMARK A/S (DK) 2013-10-01 US disclosed
US-8481697-B2 Nucleic acid base pairs DAKO DENMARK A/S (DK) 2013-07-09 US disclosed
US-20110177500-A1 IMMUNOHISTOCHEMISTRY DETECTION METHOD DAKO DENMARK AS (DK) 2011-07-21 US disclosed
EP-1907592-B1 MONOMERIC AND POLYMERIC LINKERS USEFUL FOR CONJUGATING BIOLOGICAL MOLECULES AND OTHER SUBSTANCES DAKO DENMARK AS (DK) 2011-03-09 EP disclosed
US-20100221705-A1 IN SITU HYBRIDIZATION DETECTION METHOD DAKO DENMARK APS (DK) 2010-09-02 US disclosed
US-20100120054-A1 MONOMERIC AND POLYMERIC LINKERS USEFUL FOR CONJUGATING BIOLOGICAL MOLECULES AND OTHER SUBSTANCES DAKO DENMARK APS (DK) 2010-05-13 US disclosed
US-20100105030-A1 NUCLEIC ACID BASE PAIRS DAKO DENMARK A/S (DK) 2010-04-29 US disclosed
US-20100105145-A1 METHOD OF SIMULTANEOUSLY VISUALIZING MULTIPLE BIOLOGICAL TARGETS DAKO DENMARK A/S (DK) 2010-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140080145-A1 Monomeric and Polymeric Linkers Useful For Conjugating Biological Molecules and Other Substances PCNA, DCLRE1A, TK1 TDP1 363/4885BLM 442/4885PMP22 1457/4885
US-20100105030-A1 NUCLEIC ACID BASE PAIRS NSUN3, NCL, NSUN2 TDP1 161/4885BLM 377/4885PMP22 1515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.